New Travis chairman buys
A round-up of the biggest director deals today so far.
Robert Walker, the chairman-designate of Travis Perkins, has bought his first shares in the builders' merchant. Walker was appointed to the Travis Perkins board on 30 September 2009 and he is due to take over as chairman from Tim Stevenson in May 2010.
Walker has bought a total of 25,000 shares at a total cost of £194,000.
Walker is currently chairman of WH Smith and a non-executive director of Tate & Lyle. In the past he was a non-executive director of plumbing products distributor Wolseley. Walker's executive background is in the consumer products sector having spent many decades with Procter & Gamble and PepsiCo.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Walker's appointment to the board coincided with a trading statement from Travis Perkins showing turnover 11% lower in the first nine months of 2009. However, the decline in like-for-like sales in the merchanting division slowed in the third quarter. Net debt has reduced from the £527m reported for the end of June 2009.
Top Director Buys
Value: £175,401
Value: £97,200
Value: £96,925
Value: £37,310
Value: £16,500
Top Director Sells
Value: £41,540
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published